Laila Pharmaceuticals

Laila Pharmaceuticals is an Indian drug discovery and development company focused on identifying novel therapeutic leads from phytopharmaceuticals, botanical extracts, and new chemical entities (NCEs). Established in 2007 as part of the Laila Group, the company integrates traditional phytomedicine with modern molecular biology to develop standardized bioactive formulations. Its research and development efforts primarily target unmet needs in ophthalmology (including cataracts, diabetic retinopathy, uveitis, and macular degeneration), dermatology (such as psoriasis), and mucosal inflammation (such as oral mucositis). Laila Pharmaceuticals utilizes advanced drug delivery technologies, including nanoemulsions and targeted ocular delivery systems, to enhance the bioavailability and efficacy of natural compounds like curcumin.